Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Positron emission tomography (PET) constitutes a functional imaging technique that is
harnessed to probe biological processes in vivo. PET imaging has been used to diagnose …

Nuclear medicine is defined as the use of radionuclides for diagnostic and therapeutic
applications. The imaging modalities positron emission tomography (PET) and single …

Pancreatic cancer is an extremely malignant digestive tract tumor. With the increase of
chemotherapeutic resistance of pancreatic cancer, clinical treatment is in a dilemma. Hence …

Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

Radioimmunotherapy (RIT) is FDA-approved for the clinical management of liquid
malignancies, however, its use for solid malignancies remains a challenge. The putative …

The approval of 223 RaCl 2 for cancer therapy in 2013 has heralded a resurgence of
interest in the development of α-particle emitting radiopharmaceuticals. In the last decade …

Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to radiotherapy,
chemotherapy, or a combination of these modalities, and surgery remains the only curative …

Purpose: Statins are cholesterol-depleting drugs used to treat patients with
hypercholesterolemia. Preclinically, statins disrupt trafficking of receptors present at the cell …

Simple Summary Pancreatic cancer is a leading cause of cancer death worldwide. In the
majority of patients, cancers are diagnosed at advanced stages of disease and are resistant …